Cleveland Clinic Cole Eye Institute training program covers the breadth and depth of ophthalmologic subspecialties, including cataract, cornea and external disease, glaucoma, keratorefractive and corneal surgery, neuro-ophthalmology, ocular oncology, oculoplastics and orbital surgery, pediatric ophthalmology, uveitis, vitreoretinal diseases and surgery.
This program also affords the opportunity for research to prepare interested residents for a career in academic ophthalmology.
Residents are expected to participate in basic and clinical research projects and are encouraged to present findings at national meetings.
We are excited by the continuing innovation and excellence that characterize the Cole Eye Institute.
Resources For Medical Professionals
Continuing Medical Education
Offering one of the largest hospital-based continuing medical education programs in the U.S.
Optometry Continuing Education
Inviting optometrists to learn from leading edge ophthalmologists covering the breadth and depth of subspecialties.
Distinguished Lecture Series
Providing a forum for renowned researchers to present their latest research findings.
Medical Student Clerkship Rotations
Giving students the opportunity to observe and learn from leading ophthalmologists
Observerships & Visitors
Welcoming ophthalmologists to visit and observe clinical practice, including surgery
Ophthalmology Update Newsletter
Information on state-of-the-art diagnostic and management techniques and current research.
Refer a Patient
Information for physicians who want to refer patients to Cole Eye.
Learn more about residency training available at Cole Eye.
Learn more about fellowships available at Cole Eye.
Listed below are helpful links to organizations, general peer-reviewed publications and trade-press publications.
General Peer-Reviewed Publications
Why Choose the Cole Eye Institute?
Cole Eye Institute is among the world’s most advanced eye centers. Cleveland Clinic is ranked as one of the nation's top hospitals by U.S. News & World Report. Our retina team has some of the best clinical outcomes in the field, and is passionate about leading the way in research and innovation for retinal diseases.Learn More